| Name | Title | Contact Details |
|---|
LipoScience, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Dentsply Gac is a Queensbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Patrick Treacy, Antony Koblish and Adele Oliva saw a unique opportunity for one company to demonstrate leadership and set the agenda for innovation in surgical oncology. Founded in 2015, with best-in-class innovation partners, Onkos Surgical will deliver high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients. From modular segmental systems to customized solutions and patient specific products, Onkos Surgical will partner with surgeons to provide new innovations to help address complex cases. Onkos Surgical has capabilities to increase the speed and delivery of innovation. Onkos Surgical is leveraging new technologies, such as 3D printing, to meet the unique needs of the cancer patient or surgeon. Onkos Surgical will develop products for both hard and soft-tissue applications while continuing to explore strategic partnerships to differentiate our product portfolio. With great customer responsiveness, manufacturing lead-times and quality, our vision is to be able to service and support the needs of the surgical oncologist.
We`re all about mobility. Our made-just-for-you mobility devices keep you moving through all of life`s challenges. And, as a preferred provider, we`re moving our industry ahead with state-of-the-art technology and uniquely engineered wheelchair components. We build the right chairs for people with severe physical challenges. Many are children with birth defects, such as Cerebral Palsy, Muscular Dystrophy and Spina Bifida. We also serve teens, adults and seniors challenged with severe trauma, disease and skeletal disorders. To get it right, we must continually adhere to a spider web of ever-changing state and federal laws, as well as insurance regulations. This requires a dedicated team of master ATPs, expert compliance /funding specialists and a national management team dedicated to what`s best for our clients. Thanks to our talented hardworking team of people, we`re able to accomplish our mission—one wheelchair at a time.
CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.